CoChat

Fundamentals of Cardipmetabolic Risk Factor Reduction: Achieving and Maintaining Weight Loss with Pharmacotherapy or Bariatric Surgery

Fabbrini, Elisa, Klein, Samuel · 2008 · Clinical Cornerstone

The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.

Abstract

Obesity is a major health problem in the United States and many other countries because of its high prevalence and causal relationship with serious medical comorbidities. The therapeutic options currently available to help obese patients lose weight are: (1) therapeutic lifestyle change (behavioral, dietary, and physical activity modification); (2) pharmacotherapy; and (3) bariatric surgery. Lifestyle modification is the first therapeutic choice; however, achieving a successful long-term weight loss with lifestyle intervention alone is difficult. There is increasing interest, therefore, in the use of pharmacotherapy and surgery to treat obesity. Although there are a number of antiobesity medications available, the only medications approved in the United States for long-term treatment of obesity are sibutramine and orlistat. Use of these medications results in 3% to 5% more weight loss compared with placebo after 1 year. Bariatric surgery is an effective weight loss option for obese patients, but it is restricted to patients who are considered morbidly obese (ie, with a body mass index [BMI] > or =40 kg/m(2) or a BMI of 35-39.9 kg/m(2) with > or =1 severe obesity-related medical complication).

Overview

Integrity signals

Registry

Crossref · 10.1016/s1098-3597(08)60027-7

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 52 references

Research works printed but not linked: 1

  1. American Society for Metabolic & Bariatric Surgery. Metabolic surgery expected to play bigger role in treating type 2 diabetes and other metabolic diseases. Press Release: August 22, 2007. http://www.asbs.org/Newsite07/resources/asmbs_items.htm. Accessed August 11, 2008.

Cited by

See all 9

Metadata

Authors
Fabbrini, E., & Klein, S.
Affiliations
Washington University in St. Louis (US)
Corresponding author
Klein, Samuel
Venue
Clinical Cornerstone
Publisher
Elsevier BV
Published
2008-01
Volume
9
Issue
1
Pages
41-51
ISSN
1098-3597 (ISSN-L)
OpenAlex
W1982387448
Cited by
9
References
53
Citations by year
2020: 1 · 2019: 1 · 2018: 1 · 2017: 2 · 2015: 1 · 2012: 1
FWCI
0.47
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Clinical cornerstone (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
Keywords
obesity, weight loss, bariatric surgery, sibutramine, orlistat, morbid obesity, body mass index, obesity-related comorbidities, long-term weight maintenance
MeSH terms
Orlistat, Cardiovascular Diseases, Cyclobutanes, Diabetes Mellitus, Type 2, Humans, Lactones, Obesity, Risk Factors, Weight Loss, Anti-Obesity Agents, Bariatric Surgery, Cannabinoid Receptor Modulators

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fundamentals of Cardipmetabolic Risk Factor Reduction: Achieving and Maintaining Weight Loss with Pharmacotherapy or Bariatric Surgery. https://app.cochat.ai/papers/10.1016/s1098-3597(08)60027-7
The paper
Fabbrini, E., & Klein, S. (2008). Fundamentals of Cardipmetabolic Risk Factor Reduction: Achieving and Maintaining Weight Loss with Pharmacotherapy or Bariatric Surgery. Clinical Cornerstone. https://doi.org/10.1016/s1098-3597(08)60027-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.